People: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

0.87USD
2 Jul 2015
Change (% chg)

$-0.02 (-2.31%)
Prev Close
$0.89
Open
$0.88
Day's High
$0.90
Day's Low
$0.84
Volume
127,586
Avg. Vol
253,181
52-wk High
$1.35
52-wk Low
$0.41

Search Stocks

Skelly, William 

Mr. William G. Skelly is an Independent Director of Acura Pharmaceutical Technologies, Inc. since May 1996 and served as our Chairman from October 1996 through June 2000. Since 1990, Mr. Skelly has served as Chairman, President and Chief Executive Officer of Central Biomedia, Inc. and its subsidiary SERA, Inc. From 1985 to 1990, Mr. Skelly served as President of Martec Pharmaceutical, Inc. Mr. Skelly earned a Bachelor of Arts degree from Michigan State University and a Masters of Business Administration from the University of Missouri-Kansas City.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Jones

503,424

Peter Clemens

363,160

Robert Seiser

196,948

J. Bradley Rivet

209,422

Albert Brzeczko

351,528

James Emigh

196,948
As Of  30 Dec 2014
Search Stocks